Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: The PEGASE study

Journal of Hypertension

Volumn 16, Issue 1, 1998, Pages 37-44

  Tiret, Laurence ^a   Blanc, Hervé ^a   Ruidavets, Jean Bernard ^b   Arveiler, Dominique ^c   Luc, Gérald ^d   Jeunemaitre, Xavier ^a   Tichet, Jean ^e   Mallet, Christine ^a   Poirier, Odette ^a   Plouin, Pierre François ^a   Cambien, François ^a  

^a HÔPITAL BROUSSAIS   (France)

^b MONICA Toulouse   (France)

^c MONICA Project of Strasbourg

^d MONICA Lille   (France)

^e Inst Reg Pour la Sante   (France)

Author keywords

Angiotensin converting enzyme; Angiotensin II receptor; Angiotensinogen; Essential hypertension; Genes; Myocardial infarction; Parental history; Renin angiotensin system; Stroke

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; FAMILIAL DISEASE; FEMALE; GENE FREQUENCY; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARENT; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; STROKE;

EID: 6844260524     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816010-00007     Document Type: Article

References (51)

1. Lifton RP. Genetic determinants of human hypertension. Proc Natl Acad Sci USA 1995; 92:8545-8551.
2. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71:169-180.
3. Jeunemaitre X, Charru A, Chatellier G, Dumont C, Sassano P, Soubrier F, et al. M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens 1993; 11 (suppl 5):S80-S81.
4. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994; 93:1285-1287.
5. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330:1629-1633.
6. Kamitani A, Rakugi H, Higaki J, Yi Z, Mikami H, Miki T, et al. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens 1994; 8:521-524.
7. Hegele R, Brunt H, Connelly P. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 1994; 90:2207-2212.
8. Caulfield M, Lavender P, Newell-Price J, Farral M, Kamdar S, Daniel H, et al. Linkage of the angiotensinogen gene locus to human essential hypertension in Afncan Caribbeans. J Clin Invest 1995; 96:687-692.
9. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, et al. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM Study. J Hypertens 1995; 13:311-317.
10. Iwai N, Shimoike H, Ohmichi N, Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995; 25:688-693.
11. 235-Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations. J Hypertens 1995; 13:717-722.
12. Johnson A, Simons L, Friedlander Y, Simons J, Davis D, MaCallum J. M235-T polymorphism of the angiotensinogen gene predicts hypertension in the elderly. J Hypertens 1996; 14:1061-1065.
13. Jeunemaitre X, lnoue I, Williams C, Charru A, Tichet J, Powers M, et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997; 60:1448-1460.
14. Schunkert H, Hense H-W, Gimenez-Roqueplo A, Stieber J, Keil U, Riegger GAJ, et al. The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort. Hypertension 1997; 29:628-633.
15. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet 1993; 4:59-61.
16. Arngnmsson R, Purandare S, Connor M, Walker J, Björnsson S, Soubrier F, et al. Angiotensinogen: a candidate gene involved in preeclampsia? Nature Genet 1993; 4:114-115.
17. Bonnardeaux A, Davies E, Jeunemaitre X, Féry I, Charru A, Clauser E, et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24:63-69.
18. Iwai N, Ohmichi N, Hanai K, Nakamura Y, Kinoshita M. Human SA gene locus as a candidate locus for essential hypertension. Hypertension 1994; 23:375-380.
19. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346.
20. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence from combined segregation and linkage analysis that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51:197-205.
21. Costerousse O, Allegrini J, Lopez M , Alhenc-Gelas F. Angiotensin I-converting enzyme in the human circulating mononuclear cells: genetic polymorphism of expression in T lymphocytes. Biochem J 1993; 290:33-40.
22. Cambien F, Evans A. Angiotensin I converting enzyme gene polymorphism and coronary heart disease. Eur Heart J 1995; 16 (suppl K):13-22.
23. Parra H, Arveiler D, Evans A, Cambou J, Amouyel P, Bingham A, et al. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb 1992; 12:701-707.
24. Tiret L, Bonnardeaux X, Poirier O, Ricard S, Marques-Vidal P, Evans AE. et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994; 344:910-913.
25. Tiret L, Amouyel P, Rakotovao R, Cambien F, Ducimetiere P. Testing for association between disease and linked marker loci: a log-linear model analysis. Am J Hum Genet 1991; 48:926-934.
26. 235-Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun 1993; 197:833-839.
27. Rotimi C, Morrison L, Cooper R, Oyejide C, Effiong E, Ladipo M, et al. Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension 1994; 24:591-594.
28. Forrester T, McFarlane-Anderson N, Bennet F, Wilks R, Puras A, Cooper R, et al. Angiotensinogen and blood pressure among blacks: findings from a community survey in Jamaica. J Hypertens 1996; 14:315-321.
29. Hingorani A, Sharma P, Jia H, Hopper R, Brown M. Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension 1996; 28:907-911.
30. Kiema T, Kauma H, Rantala A, Lilja R, Reunanen A, Kesäniemi Y, et al. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 1996; 28:1070-1075.
31. Walker W, Whelton P, Saito H, Russel R, Hermann J. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979; 1:287-291.
32. Bloem L, Manatunga A, Tewksbury D, Pratt J. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1995; 95:948-953.
33. Watt G, Harrap S, Foy C, Holton D, Edwards H, Davidson H, et al. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 1992; 10:473-482.
34. Kim H, Krege J, Kluckman K, Hagaman J, Hodgin J, Best C, et al. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 1995; 92:2735-2739.
35. Inoue I, Nakajima T, Williams C, Quackenbush J, Puryear R, Powers M, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99:1786-1797
36. Corvol P, Jeunemaitre X, Charru A, Kotelevtsev Y, Soubrier F. Role of the renin-angiotensin system in blood pressure regulation and in human hypertension: New insights from molecular genetics. Recent Prog Horm Res 1995; 50:287-308.
37. Staessen J, Wang J, Ginocchio G, Saavedra A, Soubrier F, Vlietinck R, et al. The insertion/deletion polymorphism of the angiotensin-converting enzyme gene and cardiovascular-renal risk: a meta-analysis [abstract]. J Hypertens 1997; 15 (suppl 4):586.
38. 1166 polymorphism. Relationships with blood pressure and cardiovascular structure. Hypertension 1996; 28:1076-1080.
39. Benetos A, Gautier S, Ricard S, Topouchian J, Asmar R, Poirier O, et al. Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996; 94:698-703.
40. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359:641-644.
41. Tiret L, Kee F, Poirier O, Nicaud N, Lecerf L, Evans AE, et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993; 341:991-992.
42. Bohn M, Berge K, Bakken A, Erikssen J, Berg K, Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction. Clin Genet 1993; 44:298-301.
43. Badenhop R, Wang X, Wilcken D. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation 1995; 91:1655-1658.
44. Markus H, Barley J, Lunt R, Bland J, Jeffery S, Carter N, et al. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995; 26:1329-1333.
45. Margaglione M, Celentano E, Grandone E, Vecchione G, Cappucci G, Giuliani N, et al. Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke. Arterioscler Thromb Vasc Biol 1996; 16:304-309.
46. Kario K, Kanai N, Saito K, Nago N, Matsuo T, Shimada K. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation 1996; 93:1630-1633.
47. Sharma P, Carter N, Barley J, Brown M. Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin I-converting enzyme. J Hum Hypertens 1994; 8:645-648.
48. Catto A, Carter AM, Barrett JH, Stickland M, Bamford J, Davies AD, et al. Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke 1996; 27:435-440.
49. Ueda S, Weir C, Inglis G, Murray G, Muir K, Lees K. Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and stroke. J Hypertens 1995; 13:1597-1601.
50. Maeda Y, Ikeda U, Ebata H, Hojo Y, Seino Y, Hayashi Y, et al. Angiotensin converting enzyme gene polymorphism in hypertensive individuals with parental history of stroke, Stroke 1996; 27:1521-1523.
51. Morris BJ, Zee RYL, Schrader AP. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest 1994; 94:1085-1089.